Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
5/2021 ceased to operate
Rebiotics Rx
Rebiotics Rx Overview
Rebiotics Rx is focused on repurposing FDA-approved antibiotics to fight antibiotic-resistant bacteria. The flagship product of Rebiotics Rx is a PEGylated Nanoliposomal-mupirocin formulation. Mupirocin has a unique mode of action, not shared by any other available antibiotic. It is active against pathogens defined as urgent and serious threats to public health, such as Neisseria gonorrhea, methicillin-resistant Staphylococcus aureus, and Streptococcus pneumonia. However, its short half-life in circulation prevents its parenteral use and limits it to topical uses. Reformulation of mupirocin by the nanoliposomes substantially increases the systemic exposure to mupirocin and prolongs its half-life, thereby enabling the parenteral activity of mupirocin and practically resulting in a novel antibiotic with demonstrated efficacy in relevant animal models.